TY  - CHAP
M1  - Book, Section
TI  - Treatment Options in Hormone-refractory Prostate Cancer
A1  - O'Donnell, Dearbhaile
A1  - Leahy, Michael
A1  - Marples, Maria
A1  - Protheroe, Andrew
A1  - Selby, Peter
Y1  - 2018
N1  - 
T2  - Problem Solving in Oncology
AB  - A  72-year-old  man  with  known  prostate  cancer  is  followed  up  regularly  in  clinic.  He  was  diagnosed  as  having  locally  advanced  cancer  and  was  started  on  goserelin  23  months  ago.  His  prostate-specific  antigen  (PSA)  level  has  continued  to  rise  over  the  past  6  months  despite  the  addition  of  bicalutamide.  He  feels  very  well  and  has  no  comorbidities.What  other  hormone  treatments  can  be  used?Is  chemotherapy  an  option?What  other  options  are  available  for  him?  
SN  - 
PB  - Clinical Publishing Oxford
CY  - New York, NY
Y2  - 2021/03/05
UR  - hemonc.mhmedical.com/content.aspx?aid=1152355083
ER  -